Loading…
Kodiak Sciences Inc. is projected to rise to $65.18 by 2027, a +58% move from its current price of $41.31. KOD is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $39.92 | $41.34 | $42.80 | +0.06% |
| Jul 14 | $39.37 | $41.36 | $43.45 | +0.12% |
| Jul 15 | $38.96 | $41.39 | $43.97 | +0.18% |
| Jul 16 | $38.62 | $41.41 | $44.41 | +0.24% |
| Jul 17 | $38.32 | $41.44 | $44.80 | +0.31% |
| Jul 18 | $38.06 | $41.46 | $45.17 | +0.37% |
| Jul 19 | $37.83 | $41.49 | $45.50 | +0.43% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $37.83 | $41.49 | $45.50 | +0.43% |
| Week 2 | $36.56 | $41.67 | $47.48 | +0.86% |
| Week 3 | $35.66 | $41.84 | $49.11 | +1.29% |
| Week 4 | $34.93 | $42.02 | $50.55 | +1.73% |
| Week 5 | $34.33 | $42.20 | $51.89 | +2.16% |
| Week 6 | $33.80 | $42.39 | $53.15 | +2.60% |
| Week 7 | $33.33 | $42.57 | $54.36 | +3.04% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Kodiak Sciences Inc. is a healthcare company described as a clinical stage biopharmaceutical company that engages in the research, development, and commercialization of therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor (VEGF) antibody biopolymer that has complete Phase 3 clinical study to treat high prevalence retinal vascular diseases; and in Phase 3 clinical study for the treatment of diabetic retinopathy, wet age-related macular degeneration (AMD), retinal vein occlusion, and diabetic macular edema, as well as in Phase 2/3 clinical study to treat wet AMD.
Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015.
Kodiak Sciences Inc. trades under the symbol KOD and sits with a current price of $40.63 and a market capitalization of $2.54B. Its market rank is 1878. The stock has a bullish longer‑term outlook in the forecast with multi‑year upside potential shown by rising average prices across the years, anchored by a current price level that aligns with several longer‑term targets.
A major floor 47.1% below — a decisive break under it would weaken the trend.
The nearest floor, 28.3% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 18.9% above — clearing it would confirm fresh momentum.
Key KOD support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of KOD market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $39.47 | Buy | $39.87 | Buy |
| MA 10 | $38.58 | Buy | $38.75 | Buy |
| MA 20 | $36.82 | Buy | $37.54 | Buy |
| MA 50 | $37.24 | Buy | $36.69 | Buy |
| MA 100 | $35.04 | Buy | $34.39 | Buy |
| MA 200 | $28.32 | Buy | $28.77 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 61.93 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 160.35 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.63 | Buy |
| ROC (12) | 11.50 | Buy |
| Bollinger %B (20,2) | 0.99 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.18 | Buy |
| Awesome (5,34) | 3.73 | Buy |
| Ultimate (7,14,28) | 61.61 | Neutral |
| Momentum (10) | 7.22 | Buy |
| Aroon Osc (25) | 88.00 | Buy |
| Hull MA (9) | 40.87 | Buy |
| ADX (14) | 14.48 | Neutral |
| ATR (14) | 1.32 | Info |
Technically, the sentiment is bullish with an RSI of 60. The 50‑day simple moving average is $37.41 and the 200‑day simple moving average is $28.04, indicating a positive trend. Immediate support is reported at $29.61 and resistance at $40.63, placing the current price near a key cap.
The 30‑day price range spans from $31.94 to $51.69, highlighting a breakout potential if price action tests the upper band.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $21.01 | $41.31 | $56.32 | 0% | Neutral | |
| $50.55 | $65.18 | $89.69 | +58% | Bullish | |
| $60.59 | $81.05 | $116.72 | +96% | Bullish | |
| $71.47 | $98.60 | $147.08 | +139% | Bullish | |
| $75.41 | $106.92 | $164.28 | +159% | Bullish | |
| $77.08 | $112.06 | $176.65 | +171% | Bullish | |
| $97.33 | $144.86 | $233.65 | +251% | Bullish | |
| $113.97 | $173.44 | $285.59 | +320% | Bullish | |
| $133.08 | $206.86 | $347.14 | +401% | Bullish | |
| $158.47 | $251.41 | $429.37 | +509% | Bullish | |
| $251.41 | $438.19 | $805.04 | +961% | Bullish | |
| $376.16 | $775.97 | $1,583.39 | +17.8x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $21.01 | $41.31 | $49.63 | +0.00% |
| August 2026 | $36.17 | $43.00 | $52.74 | +4.10% |
| September 2026 | $36.40 | $43.68 | $54.32 | +1.57% |
| October 2026 | $34.69 | $41.95 | $52.79 | -3.96% |
| November 2026 | $34.35 | $41.81 | $53.14 | -0.33% |
| December 2026 | $35.85 | $43.91 | $56.32 | +5.02% |
Click any year to see its month-by-month KOD forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect KOD to range from $21.01 to $56.32 through 2026. The $41.31 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The KOD price prediction for 2027 points to an average of $65.18 (low $50.55, high $89.69) — a potential gain of +58% on today's $41.31. Momentum favours further upside here.
In 2028, KOD is projected to trade between $60.59 and $116.72, averaging $81.05 — a potential gain of +96% from today's $41.31. That is up +24% on the projected 2027 average. Buyers look set to stay in control over this stretch.
Kodiak Sciences Inc.'s 2029 outlook centres on $98.60, within a $71.47 to $147.08 range. That is up +22% on the projected 2028 average. That marks a +139% change versus current levels. Momentum favours further upside here.
By 2030, KOD could reach as high as $164.28, with a base case around $106.92 and support toward $75.41 — roughly +159% from $41.31. Buyers look set to stay in control over this stretch.
Expect KOD to range from $77.08 to $176.65 through 2031. The $112.06 average target implies a +171% move from current prices. That is up +5% on the projected 2030 average. Momentum favours further upside here.
The KOD price prediction for 2032 points to an average of $144.86 (low $97.33, high $233.65) — a potential gain of +251% on today's $41.31. Buyers look set to stay in control over this stretch.
In 2033, KOD is projected to trade between $113.97 and $285.59, averaging $173.44 — a potential gain of +320% from today's $41.31. That is up +20% on the projected 2032 average. Momentum favours further upside here.
Kodiak Sciences Inc.'s 2034 outlook centres on $206.86, within a $133.08 to $347.14 range. That is up +19% on the projected 2033 average. That marks a +401% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, KOD could reach as high as $429.37, with a base case around $251.41 and support toward $158.47 — roughly +509% from $41.31. Momentum favours further upside here.
Expect KOD to range from $251.41 to $805.04 through 2040. The $438.19 average target implies a +961% move from current prices. That is up +74% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The KOD price prediction for 2050 points to an average of $775.97 (low $376.16, high $1,583.39) — a potential gain of +17.8x on today's $41.31. Momentum favours further upside here.
Investing $1,000 in KOD today (≈ 24.207214 KOD) could be worth
$18,784.03
+$17,784.03 (+1778%) by 2050 · US Dollar
Based on the average projected KOD price of $775.97 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in KODwould be worth at today's price.
$1,000 invested in KOD on Jul 10, 2025 (≈ 222.717161 KOD) would be worth
$9,200.45
+$8,200.45 (+820.0%) today · 9.20× · US Dollar
Based on a KOD entry price of $4.49 vs. today's $41.31.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $38.54 | $1,071.87 | +7.2% |
| 1 month ago | $31.41 | $1,315.19 | +31.5% |
| 3 months ago | $43.11 | $958.25 | -4.2% |
| 6 months ago | $28.06 | $1,472.2 | +47.2% |
| 1 year ago | $4.49 | $9,200.45 | +820.0% |
| All time (5.0y) ago | $93.16 | $443.43 | -55.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our KOD forecast.
Our base-case forecast reaches $83.00 around 2029.
Implied market cap at $83.00: $5.19B
The multi‑year forecast shows a path of rising averages from 2026 onward, with 2026 implied average price of $40.63 and 2027 at $64.50, 2028 at $80.66, 2029 at $97.87, and 2030 at $105.46. The forecast also indicates substantial upside by 2031–2050, with 2030’s average at $105.46 and maximums reaching $163.90 (ROI 159.6) and bullish sentiment across 2027–2050. By 2040 the average price is $437.59 and the max is $817.63 (ROI 977), with 2050 averaging $765.35 and a max of $1,592.81 (ROI 1783.7).
These figures reflect an upward trajectory with persistent bullish sentiment, though the numbers are estimates and not guarantees. The forecast also shows today’s price aligning with longer‑term targets while acknowledging elevated volatility is possible given the 70% annualized volatility figure.
Tap a question to reveal the answer.
The 2030 forecast shows a min of $73.57, an average of $105.46, and a max of $163.90, with a forecasted ROI of 159.6 and a bullish sentiment.
From 2027 onward the forecast shows bullish sentiment with rising averages (e.g., $64.50 in 2027 and $105.46 in 2030) and sizable max targets (e.g., $234.27 in 2032 and $285.64 in 2033). The projections include positive ROI figures such as 58.7% in 2027, 98.5% in 2028, 140.9% in 2029, and higher in later years, but these are estimates and not guarantees.
Yes. The forecast shows max values above $200 in several years, including $234.27 in 2032 and $285.64 in 2033, with earlier years reaching up toward the mid‑to‑high range of the forecast path.
The current price is $40.63. The 30‑day range is between $31.94 and $51.69, with a nearby resistance noted at $40.63 and support at $29.61.
The 2040 forecast shows an average price of $437.59 with a max of $817.63 (ROI 977) and bullish sentiment. The 2050 forecast shows an average of $765.35 with a max of $1,592.81 (ROI 1783.7) and bullish sentiment. These figures illustrate substantial long‑term upside within the projected path.
Kodiak Sciences Inc. Community Discussion
0Share your Kodiak Sciences Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.